Hefei Lifeon Pharmaceutical Co., Ltd. (SHE:003020)
27.26
-0.09 (-0.33%)
Jan 19, 2026, 4:00 PM EST
SHE:003020 Revenue
Hefei Lifeon Pharmaceutical had revenue of 348.25M CNY in the quarter ending September 30, 2025, a decrease of -2.12%. This brings the company's revenue in the last twelve months to 1.47B, down -1.82% year-over-year. In the year 2024, Hefei Lifeon Pharmaceutical had annual revenue of 1.52B, down -20.11%.
Revenue (ttm)
1.47B
Revenue Growth
-1.82%
P/S Ratio
3.51
Revenue / Employee
1.01M
Employees
1,456
Market Cap
5.17B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.52B | -382.30M | -20.11% |
| Dec 31, 2023 | 1.90B | -678.55M | -26.31% |
| Jan 1, 2023 | 2.58B | 306.09M | 13.46% |
| Dec 31, 2021 | 2.27B | 378.96M | 20.01% |
| Dec 31, 2020 | 1.89B | 244.26M | 14.80% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Pulike Biological Engineering | 1.10B |
| ChemPartner PharmaTech | 1.07B |
| Beijing Bohui Innovation Biotechnology Group | 834.38M |
| Hangzhou Biotest Biotech | 478.69M |
| Assure Tech (Hangzhou) | 462.72M |
| Innovita Biological Technology | 430.96M |
| Beijing Scitop Bio-tech | 351.47M |
| Obio Technology (Shanghai) Corp. | 244.64M |